AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

NASDAQ:ARNAArena Pharmaceuticals SEC Filings & 10K Form

$58.14
+1.23 (+2.16 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$54.78
Now: $58.14
$58.48
50-Day Range
$45.09
MA: $50.09
$58.91
52-Week Range
$32.95
Now: $58.14
$64.48
Volume606,127 shs
Average Volume614,202 shs
Market Capitalization$2.93 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.33

SEC Filings

Arena Pharmaceuticals (NASDAQ:ARNA) SEC Filings

DateFilerForm TypeView
05/27/2020
3:13 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2020
6:31 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:46 PM
Arena Pharmaceuticals (Filer)
Form DEFA14A
04/01/2020
3:06 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
7:24 AM
Arena Pharmaceuticals (Issuer)
Schmidt Joan (Reporting)
Form 4/A
03/17/2020
5:47 PM
Arena Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
5:43 PM
Arena Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/17/2020
5:42 PM
Arena Pharmaceuticals (Issuer)
Schmidt Joan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:25 PM
Arena Pharmaceuticals (Issuer)
Schmidt Joan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/03/2020
5:17 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:15 PM
Arena Pharmaceuticals (Issuer)
Klassen Preston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:13 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:10 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
5:02 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
6:43 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
6:40 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
6:37 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
7:02 AM
Arena Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/27/2020
2:11 PM
Arena Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/13/2020
3:12 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
3:50 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
4:44 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
7:14 PM
Arena Pharmaceuticals (Issuer)
WOODS RANDALL E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
7:02 AM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2019
7:22 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:21 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:20 PM
Arena Pharmaceuticals (Issuer)
Klassen Preston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:19 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:18 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:17 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
8:05 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
8:03 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:05 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2019
5:59 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/17/2019
5:56 PM
Arena Pharmaceuticals (Issuer)
WOODS RANDALL E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:53 PM
Arena Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:51 PM
Arena Pharmaceuticals (Issuer)
Nova Tina Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:48 PM
Arena Pharmaceuticals (Issuer)
NEIL GARRY ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:46 PM
Arena Pharmaceuticals (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:43 PM
Arena Pharmaceuticals (Issuer)
GALLAHUE KIERAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:41 PM
Arena Pharmaceuticals (Issuer)
FETZER OLIVER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:38 PM
Arena Pharmaceuticals (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:51 PM
Arena Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/14/2019
3:16 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:19 PM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:05 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
8:15 AM
Arena Pharmaceuticals (Filer)
Form DEFA14A
04/30/2019
8:00 AM
Arena Pharmaceuticals (Filer)
Form DEF 14A
03/20/2019
12:11 PM
Arena Pharmaceuticals (Filer)
Form CT ORDER
03/08/2019
5:15 PM
Arena Pharmaceuticals (Issuer)
Nova Tina Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
4:22 PM
Arena Pharmaceuticals (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
02/11/2019
8:32 AM
Arena Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/04/2019
6:35 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
9:07 AM
Arena Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/25/2019
8:31 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
3:26 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
8:37 AM
Arena Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/08/2019
8:04 PM
Arena Pharmaceuticals (Issuer)
Klassen Preston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:02 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:01 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:00 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
7:58 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
7:52 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
3:25 PM
Arena Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
3:20 PM
Arena Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2018
3:15 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
8:24 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2018
7:12 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
9:38 AM
Arena Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2018
3:11 PM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:04 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2018
7:03 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
3:05 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2018
3:11 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2018
3:03 PM
Arena Pharmaceuticals (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G
08/17/2018
4:17 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
9:21 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
3:01 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2018
8:15 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2018
3:14 PM
Arena Pharmaceuticals (Issuer)
GALLAHUE KIERAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2018
3:12 PM
Arena Pharmaceuticals (Issuer)
GALLAHUE KIERAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2018
3:08 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
3:35 PM
Arena Pharmaceuticals (Issuer)
WOODS RANDALL E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:34 PM
Arena Pharmaceuticals (Issuer)
Nova Tina Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:32 PM
Arena Pharmaceuticals (Issuer)
NEIL GARRY ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:31 PM
Arena Pharmaceuticals (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:30 PM
Arena Pharmaceuticals (Issuer)
FETZER OLIVER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:29 PM
Arena Pharmaceuticals (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:27 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2018
3:06 PM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
3:02 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2018
3:05 PM
Arena Pharmaceuticals (Filer)
Form DEF 14A
04/18/2018
4:31 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2018
9:11 AM
Arena Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
04/02/2018
6:00 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2018
3:10 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2018
3:07 PM
Arena Pharmaceuticals (Filer)
Form 424B5
03/20/2018
4:28 PM
Arena Pharmaceuticals (Filer)
Form 424B5
03/19/2018
3:10 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2018
4:26 PM
Arena Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.